The treatment of pyoderma gangrenosum using etanercept
- 31 March 2006
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 54 (3), S128-S134
- https://doi.org/10.1016/j.jaad.2005.10.058
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Poor Prognosis of Arthritis-Associated Pyoderma GangrenosumArchives of Dermatology, 2004
- Elevated Serum Granulocyte Colony-Stimulating Factor Levels in Patients With Active Phase of Sweet Syndrome and Patients With Active Behçet DiseaseArchives of Dermatology, 2004
- Treatment of SclerodermaArchives of Dermatology, 2002
- Infliximab (Anti–Tumor Necrosis Factor α Antibody)Archives of Dermatology, 2001
- Cellular and molecular dynamics in exercise-induced urticarial vasculitis lesions.Archives of Dermatology, 1998
- Pyoderma gangrenosum: Classification and managementJournal of the American Academy of Dermatology, 1996
- The Evolution of Pyoderma GangrenosumThe American Journal of Dermatopathology, 1993
- The Expression of Endothelial Leukocyte Adhesion Molecule-1 (ELAM-1), Intercellular Adhesion Molecule-1 (ICAM-1), and Vascular Cell Adhesion Molecule-1 (VCAM-1) in Experimental Cutaneous Inflammation: A Comparison of Ultraviolet B erythema and Delayed HypersensitivityJournal of Investigative Dermatology, 1991
- Receptor Binding and Activation of Polymorphonuclear Neutrophils by Tumor Necrosis Factor-AlphaJournal of Leukocyte Biology, 1987
- PYODERMA (ECHTHYMA) GANGRENOSUMArchives of Dermatology and Syphilology, 1930